Found 31 matching trials
Effect of Oral Supplements for Influenza Vaccine Response NA The aim of this clinical trial is to explore the efficacy of fatty acid and...
Show More Location
Tsinghua University
Learn More & Join Trial
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age PHASE3 A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Show More Location
MHAT St. Ekaterina
Learn More & Join Trial
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age PHASE2 This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Show More Learn More & Join Trial
A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older PHASE3 Influenza is an acute respiratory disease caused by influenza viruses. Ther...
Show More Location
Guanyun County Center for Disease Control and Prevention
Learn More & Join Trial
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age PHASE3 This Phase 3/4, randomized, observer-blind, multi-center study, stratified ...
Show More Location
302 AusTrials Pty Ltd
Learn More & Join Trial
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults PHASE1 This is a Phase 1, single-site, open-label, comparator-controlled dose esca...
Show More Location
Duke Vaccine and Trials Unit
Learn More & Join Trial
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age PHASE3 The primary objectives of this study are to evaluate the safety and reactog...
Show More Location
Pinnacle Research Group, Llc
Learn More & Join Trial
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age PHASE3 The purpose of this study is to assess the immunogenicity and safety of GSK...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults PHASE2 This Phase 2, randomized, observer-blind, antigen and adjuvant dose-ranging...
Show More Location
03607 - PCRN_Paratus Clinical Research
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults PHASE1 Healthy adults will be once administered GC3114A(High-dose Quadrivalent inf...
Show More Location
Korea University Guro Hospital
Learn More & Join Trial